Outcomes After Isolated Aortic Valve Replacements in Patients With Chronic Obstructive Pulmonary Disease

Abstract

Chronic obstructive pulmonary disease (COPD) is a frequently encountered co-morbidity and is 1 of the main culprits for inoperability in cardiac surgeries among patients with aortic stenosis (AS). 1 Mok M Nombela-Franco L Dumont E Urena M DeLarochellière R Doyle D Villeneuve J Côté M Ribeiro HB Allende R Laflamme J DeLarochellière H Laflamme L Amat-Santos I Pibarot P Maltais F Rodés-Cabau J. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes. JACC Cardiovasc Interv. 2013; 6: 1072-1084 Crossref PubMed Scopus (82) Google Scholar ,2 Kumbhani DJ Kapadia SR Jneid H. Transcatheter or surgical aortic valve replacement in patients with chronic lung disease? The answer, my friend, is blowin’ in the Wind. J Am Heart Assoc. 2018; 7e008933 Crossref Google Scholar Aortic valve replacement (AVR) through surgical approach (surgical aortic valve replacement [SAVR]) carries a high risk of morbidity and mortality in patients with COPD on home-oxygen (home-O2), 3 Kumar K Morris CC Samhan A Herman T Chau T Lantz G Chadderdon SM Song HK Zahr FE Golwala H. Intermediate-term outcomes following transcatheter aortic valve implantation in patients with a history of supplemental home oxygen use. Am J Cardiol. 2022; 167: 159-160 Abstract Full Text Full Text PDF Scopus (0) Google Scholar ,4 Dvir D Waksman R Barbash IM Kodali SK Svensson LG Tuzcu EM Xu K Minha S Alu MC Szeto WY Thourani VH Makkar R Kapadia S Satler LF Webb JG Leon MB Pichard AD. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic transcatheter Valve). J Am Coll Cardiol. 2014; 63: 269-279 Crossref PubMed Scopus (81) Google Scholar which makes AVR through transcatheter approach (transcatheter aortic valve implantation [TAVI]) an increasingly attractive option in this patient population. 5 Doldi P Steffen J Orban M Theiss H Sadoni S Hagl C Massberg S Hausleiter J Deseive S Braun D. Clinical outcome following transcatheter aortic valve implantation in patients with chronic obstructive pulmonary disease. JACC Cardiovasc Interv. 2022; 15: 1188-1190 Crossref Scopus (1) Google Scholar However, the outcomes of home-O2 users among patients with AS and COPD who undergo different treatment strategies are not well understood. Hence, we compared the outcomes of home-O2 users and nonusers among patients with AS and COPD from a nationwide registry.